Pharmacogenetics of Major Depression: Insights from Level 1 of the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Trial

Author： Lekman Magnus  

Publisher： Adis International

ISSN： 1177-1062

Source： Molecular Diagnosis & Therapy, Vol.12, Iss.5, 2008-01, pp. : 321-330

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Treatment of Psychotic Major Depression: Is There a Role for Adjunctive Psychotherapy?

By  

Psychotherapy and Psychosomatics, Vol. 76, Iss. 5, 2007-08 ,pp. : 271-277

Karger

Access to resources Recommend Favorite

The Treatment of Major Depression in Older and Younger Psychiatric Inpatients

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 37, Iss. 4, 1989-04 ,pp. : 393-393

John Wiley & Sons Inc

Access to resources Recommend Favorite

Depression Does Not Affect the Treatment Outcome of CBT for Panic and Agoraphobia: Results from a Multicenter Randomized Trial

By  

Psychotherapy and Psychosomatics, Vol. 81, Iss. 3, 2012-03 ,pp. : 161-172

Karger

Access to resources Recommend Favorite

Harm Avoidance as a Mediator of Treatment Response to Antidepressant Treatment of Patients with Major Depression

By  

Psychotherapy and Psychosomatics, Vol. 79, Iss. 2, 2010-01 ,pp. : 116-122

Karger

Access to resources Recommend Favorite

A Clinical View of BDNF-TrkB Signaling in the Treatment of Major Depression

By  

Current Signal Transduction Therapy, Vol. 2, Iss. 3, 2007-09 ,pp. : 186-189

Bentham Science Publishers

Access to resources Recommend Favorite